SYK and cancer: Further immunoblotting of representative epithelial or mesenchymal markers showed that stable SYK knockdown influenced the expression of two typical canonical EMT markers: it increased vimentin levels and decreased E-cadherin levels in all five tested cancer cell lines with MET amplification or EGFR mutation.